Yang Sun

Yang Sun

Auto-generated profile, based on publicly available information

Yang Sun

Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine Air Force Medical University Xi'an Shaanxi China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2021 in Oncogenesis
Verified
Journal Article
Open access
PDF file
YSYang Sun
Yang Sun
CYChen Ye
Chen Ye
WTWen Tian
Wen Tian
WYWen Ye
Wen Ye
YGYuan-Yuan Gao
Yuan-Yuan Gao
XLXiao-Qiang Li
Xiao-Qiang Li
Transient receptor potential canonical (TRPC) channels are the most prominent nonselective cation channels involved in various diseases. However, the function, clinical significance, and molecular mechanism of TRPCs in colorectal cancer (CRC) progression remain unclear. In this study, we identified that TRPC1 was the major variant gene of the TRPC family in CRC patients. TRPC1 was upregulated in CRC tissues compared with adjacent normal tissues and high expression of TRPC1 was associated with more aggressive tumor progression and poor overall survival. TRPC1 knockdown inhibited cell proliferation, cell-cycle progression, invasion, and migration in vitro, as well as tumor growth in vivo; whereas TRPC1 overexpression promoted colorectal tumor growth and metastasis in vitro and in vivo. In addition, colorectal tumorigenesis was significantly attenuated in Trpc1-/- mice. Mechanistically, TRPC1 could enhance the interaction between calmodulin (CaM) and the PI3K p85 subunit by directly binding to CaM, which further activated the PI3K/AKT and its downstream signaling molecules implicated in cell cycle progression and epithelial-mesenchymal transition. Silencing of CaM attenuated the oncogenic effects of TRPC1. Taken together, these results provide evidence that TRPC1 plays a pivotal oncogenic role in colorectal tumorigenesis and tumor progression by activating CaM-mediated PI3K/AKT signaling axis. Targeting TRPC1 represents a novel and specific approach for CRC treatment.

4 April 2012 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
PDF file
SSShu‐Wei Song
Shu‐Wei Song
YSYang Sun
Yang Sun
BSBei‐Lin Su
Bei‐Lin Su
CLChong Liu
Chong Liu
CYChu Yang
Chu Yang
DSDing‐Feng Su
Ding‐Feng Su
SUMMARY: Background:Stroke is the second most common cause of death and a major cause of disability worldwide. Risperidone is an atypical antipsychotic drug that may increase the risk of stroke. The present work examined whether risperidone enhances the vulnerability to stroke in hypertensive rats and the potential mechanisms underlying such action.Methods:Experiment 1: Wistar‐Kyoto (WKY) rats, spontaneously hypertensive rats (SHRs) and stroke‐prone SHRs (SHR‐SPs) were treated with risperidone (0.8 and 2.4 mg/kg/d) or vehicle for 30 consecutive days. Tissue damage in response to middle cerebral artery occlusion (MCAO) was measured microscopically. The activity of superoxide dismutase, glutathione peroxidase, the levels of malondialdehyde were also determined. Experiment 2: Survival data were recorded in SHR‐SPs that received daily risperidone perpetually. Experiment 3: Effect of risperidone on interleukin‐6 and tumor necrosis factor‐α was examined in quiescent or LPS‐activated cortical microglias from WKY rats. Experiment 4: Potential damage of risperidone exposure to neurons was examined in primary neuronal culture obtained from WKY rats, SHRs, and SHR‐SPs.Results:Risperidone increased infarct areas upon MCAO in SHR‐SPs and SHRs, but not in WKY rats. Survival time in SHR‐SPs was shortened by risperidone. Apoptosis was augmented by risperidone through enhanced Bax. Risperidone also increased endothelial injury.Conclusions:Risperidone enhances the vulnerability to stroke in hypertensive rats through increasing neuronal apoptosis and endothelial injury.

14 August 2015 in Head & Neck
Verified
Journal Article
Open access
PDF file
SSSalwa Suliman
Salwa Suliman
HPHimalaya Parajuli
Himalaya Parajuli
YSYang Sun
Yang Sun
AJAnne Christine Johannessen
Anne Christine Johannessen
AFAnna Finne–Wistrand
Anna Finne–Wistrand
DCDaniela-Elena Costea
Daniela-Elena Costea
Background: Microenvironmental cues play a major role in head and neck cancer. Biodegradable scaffolds used for bone regeneration might also act as stimulative cues for head and neck cancer. The purpose of this study was to establish an experimental model for precise and noninvasive evaluation of tumorigenic potential of microenvironmental cues in head and neck cancer.Methods: Bioluminescence was chosen to image tumor formation. Early neoplastic oral keratinocyte (DOK) cells were luciferase‐transduced (DOKLuc), then tested in nonobese diabetic severe combined immunodeficient IL2rγnull mice either orthotopically (tongue) or subcutaneously for their potential as “screening sensors” for diverse microenvironmental cues.Results: Tumors formed after inoculation of DOKLuc were monitored easier by bioluminescence, and bioluminescence was more sensitive in detecting differences between various microenvironmental cues when compared to manual measurements. Development of tumors from DOKLuc grown on scaffolds was also successfully monitored noninvasively by bioluminescence.Conclusion: The model presented here is a noninvasive and sensitive model for monitoring the impact of various microenvironmental cues on head and neck cancer in vivo. © 2015 The Authors Head & Neck Published by Wiley Periodicals, Inc. Head Neck 38: E1177–E1187, 2016

6 December 2025 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
SMShan Miao
Shan Miao
WHWei Hua
Wei Hua
JWJin Wang
Jin Wang
LLLong Li
Long Li
YSYang Sun
Yang Sun
SMShanbo Ma
Shanbo Ma